Prothena to Report Second Quarter 2025 Financial Results on August 4
Consistent with past practice, the Company will not be conducting a conference call in conjunction with the financial results release on August 4.
About Prothena
Prothena Corporation plc is a late-stage clinical biotechnology company with expertise in protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare peripheral amyloid diseases. Fueled by its deep scientific expertise built over decades of research, Prothena is advancing a pipeline of therapeutic candidates for a number of indications and novel targets for which its ability to integrate scientific insights around neurological dysfunction and the biology of misfolded proteins can be leveraged. Prothena's pipeline includes both wholly-owned and partnered programs being developed for the potential treatment of diseases including ATTR amyloidosis with cardiomyopathy, Alzheimer's disease, Parkinson's disease and a number of other neurodegenerative diseases. For more information, please visit the Company's website at www.prothena.com and follow the Company on X (formerly Twitter) @ProthenaCorp.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250728982522/en/
Contacts
Mark Johnson, CFA, Vice President, Investor Relations650-417-1974, mark.johnson@prothena.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
25 minutes ago
- Yahoo
Benfica in talks with Wolfsburg for Mohamed Amoura!
The Portuguese newspaper Record reports that Benfica has set its sights on Algerian international Mohamed Amoura to strengthen its attacking lineup during this summer transfer window. Mohamed Amoura is making headlines in Record, which confirms Benfica's strong interest in the player, thanks to his technical skills and standout performances with his German club. Benfica wants to strengthen its attack with Amoura! Originally from Jijel, Amoura shone last season, netting 10 goals and providing 12 assists in 34 matches. This versatile forward has impressed head coach Bruno Lage and sporting director Rui Costa, both convinced he can make a real difference for the team. Despite Wolfsburg's hefty asking price of 40 million euros, Benfica plans to submit an official offer to finalize the deal, knowing the German club had signed the player just a year ago for only 18 million euros. According to Record, if the deal goes through, it would become the most expensive transfer in the Portuguese club's history.
Yahoo
25 minutes ago
- Yahoo
Getafe agree £10m Sunderland sale
La Liga outfit Getafe have early this week agreed on the sale of a member of the club's defensive ranks to Premier League side Sunderland. The player in question? Omar Alderete. Alderete, for his part, is a 28-year-old Paraguayan international, who has been plying his trade on the books of Getafe since the summer of 2023. Across the time since, the stopper – who chiefly operates in a central role but is also capable of filling in at left-back – managed to establish himself as a leading figure in the Azulones' backline. With such form, though, comes inevitable outside interest. And as alluded to above, this week, as much has culminated in Alderete being lured away from the Estadio Coliseum. As per a report from transfer insider Fabrizio Romano: 'Omar Alderete to Sunderland, here we go! Deal sealed with Getafe for £10m fee. Contract until June 2029. All done.' Conor Laird – GSFN
Yahoo
25 minutes ago
- Yahoo
Hiscox appoints Harriet Turner to lead SML cover
Global specialist insurer Hiscox has appointed Harriet Turner to lead new sexual molestation liability (SML) cover in its London Market business. The new offering will provide coverage for claims related to sexual misconduct within the workplace. Turner's experience encompasses various roles including underwriting at Beazley and managing different classes of business including employment practices liability and private directors and officers. The SML cover is designed to address the specific risks of sexual misconduct allegations for employees, offering a safeguard for global "large organisations" across diverse sectors, including but not limited to health, social care, leisure and financial services. The coverage extends to the costs associated with legal proceedings and any financial settlements or damages awarded during the policy period. Furthermore, Hiscox has partnered with Control Risks, a global risk consultancy, to provide additional services to SML clients. These services include evaluations of the organisation's risk management and compliance strategies before the policy is bound, with recommendations for any necessary enhancements. Turner is scheduled to start her new role within the Hiscox London Market General Liability team in September 2025, operating from the London office. Hiscox London Market's casualty divisional director Colin Buchanan said: 'Expanding into sexual molestation liability broadens out our existing liability offering and responds to an increasing demand for this type of cover from clients and brokers. 'We look forward to welcoming Harriet to the team, whose background in underwriting liability products will establish Hiscox as a go-to market for sexual molestation liability protection.' In June, Hiscox rolled out a new Cargo API solution to facilitate the underwriting process for small cargo and stock throughout risks. "Hiscox appoints Harriet Turner to lead SML cover " was originally created and published by Life Insurance International, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
